Alpha-D-Arabinofuranosylamine, 2-deoxy-2-fluoro- (9CI) is a synthetic nucleoside analog characterized by the presence of a fluorine atom at the 2-position of the sugar moiety, which is a modified form of arabinofuranose. This compound features an amino group, which contributes to its potential biological activity, particularly in the context of antiviral and anticancer research. The substitution of a hydroxyl group with a fluorine atom enhances the stability and bioavailability of the molecule, making it an interesting candidate for further pharmacological studies. Its structure allows it to mimic natural nucleosides, potentially interfering with nucleic acid synthesis in target organisms. The compound is typically studied for its effects on cellular processes and its ability to inhibit specific enzymes involved in nucleic acid metabolism. As with many nucleoside analogs, its efficacy and safety profile are critical for its potential therapeutic applications, necessitating thorough investigation in preclinical and clinical settings.

alpha-D-Arabinofuranosylamine, 2-deoxy-2-fluoro- (9CI)

149624-20-4: Alpha-D-Arabinofuranosylamine, 2-deoxy-2-fluoro- (9CI) is a synthetic nucleoside analog characterized by the presence of a fluorine atom at the 2-position of the sugar moiety, which is a modified form of arabinofuranose. This compound features an amino group, which contributes to its potential biological activity, particularly in the context of antiviral and anticancer research. The substitution of a hydroxyl group with a fluorine atom enhances the stability and bioavailability of the molecule, making it an interesting candidate for further pharmacological studies. Its structure allows it to mimic natural nucleosides, potentially interfering with nucleic acid synthesis in target organisms. The compound is typically studied for its effects on cellular processes and its ability to inhibit specific enzymes involved in nucleic acid metabolism. As with many nucleoside analogs, its efficacy and safety profile are critical for its potential therapeutic applications, necessitating thorough investigation in preclinical and clinical settings.

<p>2-Deoxy-2-Fluoro-a-D-arabinofuranosylamine is a novel antiviral agent that is synthesized from 2,4,6-trichlorobenzoyl chloride and 2,4,6-trifluorophenylglycine. It has been shown to be effective in inhibiting the replication of HIV and HSV types 1 and 2. This compound also has anticancer activity against colorectal cancer cells. The synthesis of this compound results in high purity with a high yield.</p>

CAS 149624-20-4

alpha-D-Arabinofuranosylamine, 2-deoxy-2-fluoro- (9CI)

2-Deoxy-2-Fluoro-a-D-arabinofuranosylamine

Ref: 3D-ND89871